Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Should Biotech Investors Go Where Institutions Won't?
Should Biotech Investors Go Where Institutions Won't?
Should Biotech Investors Go Where Institutions Won't?
Submitted by
admin
on July 7, 2011 - 12:04pm
Source:
Investopedia
News Tags:
investors
biotech
Aeterna Zentaris
YM BioSciences
Ziopharm
Oncothyreon
Seattle Genetics
Exelixis
MannKind
MELA Sciences
Neoprobe
Zalicus
Headline:
Should Biotech Investors Go Where Institutions Won't?
Do Not Allow Advertisers to Use My Personal information
